In this article we will discuss Durvalumab (Indications-2). So, let’s get started.
- Small Cell Lung Cancer
- Durvalumab, in combination with etoposide and either carboplatin or cisplatin, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).